Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion. -- Ignore unavailable to you. Want to Upgrade?

To: Jim Bishop who wrote (62824)	9/11/2000 4:48:12 PM
From: Dave Gore	Respond to of 150070

POI.....oh, you mean lavendar paste?

To: Jim Bishop who wrote (62824)	9/11/2000 5:20:30 PM
From: myturn	Respond to of 150070

XPOR, volume and price up ten fold today. Look at the news that came out late this afternoon. Original OS on XPOR was only 6 million. The debentures just converted $375,000 worth of stock; 8.8 million shares. Now the debentures own the company and the stock for a mere $375,000. Wow, wow, wow,wow. Now, they are going to turn their $375,000 into millions of dollars. A clever way of getting additional funding for the company or management was not thinking clearly when they did their debentures. Someone sleeping with someone on this deal. LOL FREE Complaint SiteRelated Quotes XPOR.OB 0.100000 +0.050000 delayed 20 mins - disclaimer Monday September 11, 3:08 pm Eastern Time Press Release Explore Technologies Lenders Convert Debentures Into Equity VANCOUVER, B.C.--(BUSINESS WIRE)--Sept. 11, 2000--Explore Technologies Inc.(OTCBB:XPOR - news) wishes to announce that on Friday September 8th, 2000, debenture holders gave notice to convert their $370,000 debenture loan into common shares of the company at $0.0425 per share (being 20% under the average trading price for the previous 5 days) under the terms of the debenture agreement. Certain statements contained herein are ``forward looking statements'' (as such term is defined in the Private Securities Litigation Reform Act of 1995.) These statements are based upon the belief of the Company's management as well as assumptions made beyond information currently available to Company Management. Because such 'forward looking statements`` are subject to risks and uncertainties, actual results may differ materially from those expressed or implied. Such ''forward looking`` statements include, but are not limited to, competitive factors, general economic conditions, customer relations, relationships with Vendors, government supervision and regulation, product introductions and acceptance, technological changes in industry practices and other factors discussed in filings made by the Company with the Security and Exchange Commission. -------------------------------------------------------------------------------- Contact: Mr. Rod Jao Explore Technologies Inc. Tel: 604/644-8880 Fax: 604/689-8988 JUST MY OPINION. THIS IS NOT A BUY OR SELL RECO. Cheers RG

To: Jim Bishop who wrote (62824)	9/11/2000 7:09:28 PM
From: LawStor	Respond to of 150070

Jim, Got to love THAT chick from THATlook.com but got to love this more, letting the Germans buy first in a.m. News after the dinger. Check it out. See ya at the top of the grade easy point I think. thatlook.com to Acquire Breast Implant Distributor Business Editors/Health & Medical Writers STROUDSBURG, Pa.--(BW HealthWire)--Sept. 11, 2000--thatlook.com (OTC-BB:THAT) today announced that it has signed a Letter of Intent to acquire Hutchison International, Inc., of Baton Rouge, Louisiana, for 3 million shares. The closing of the acquisition will occur upon completion of thatlook's due diligence work and the signing of the Definitive Acquisition Agreement. Management of thatlook.com estimates that this work will be completed by sometime near the end of the current year. Hutchison International is the exclusive North American distributor of breast implants developed and manufactured by Biosil Ltd. of the United Kingdom. The Biosil breast implants currently have the number one market position in both the United Kingdom and Spain, and have the number two position in all of Europe. Hutchison is nearing completion of the clinical studies required to receive Food and Drug Administration (FDA) approval to market the Biosil implants in the United States, with over 2,000 patients currently enrolled. Hutchison expects to present the studies for FDA review in approximately 3 - 4 months. Based upon historical approval times for medical devices of this type, Hutchison expects to receive marketing approval within approximately six months of its Pre-Marketing Approval application. The market for breast implants in the United States is currently a duopoly, shared by Inamed Corp. (NASDAQ: IMDC) and Mentor Corp. (NASDAQ:MNTR). According to the American Society of Plastic Surgeons (www.plasticsurgery.org) there were over 167,000 breast augmentation surgeries in the United States in 1999, and this market has been growing at a 26% compound annual rate since 1992. At an average selling price to the doctor of $1,050, this results in a $175 million annual market. Gerard Powell, President of thatlook.com, made the following observations regarding the pending acquisition: "We are very excited to have the opportunity to ally ourselves with a well-respected product in a rapidly-growing, very high gross margin marketplace. We believe Hutchison will receive the next immediate FDA marketing approval granted for breast implants. Based on currently available information, we expect the next implant to be approved after ours will be at least a year later. This will give us a substantial window of opportunity to establish the Biosil product as a strong third competitor in this market. "Furthermore, this acquisition is a natural extension of our increasingly dominant position in providing marketing services to cosmetic surgeons. We believe we can dramatically accelerate the acceptance and use of the Biosil products by making them available to our network of doctors. We expect to continue searching for other products and services we can acquire to leverage with our physician base. "Lastly, we are very pleased to be able to add John Hutchison, the founder of Hutchison International, to our management team. His ongoing involvement will be an important element in driving our rapid penetration of this market once we receive the necessary FDA marketing approvals." About thatlook.com: thatlook.com is a direct response, marketing services company serving a network of physicians that specialize in performing elective, cosmetic procedures. Using a combined, multi-media approach, including the Internet, television, radio, print and direct mail, thatlook.com generates financially qualified, and purchase-minded patient traffic to its network of member physicians. thatlook.com's (OTC-BB: THAT) Internet web site is: thatlook.com Investor relations information is at: 4-you.com This News Release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct. --30--des/ph* CONTACT: thatlook.com by Zazoff Associates, LLC Alan Zazoff, 973/515-8515 Zazoff_Alan@msn.com KEYWORD: PENNSYLVANIA LOUISIANA INDUSTRY KEYWORD: MEDICAL MEDICAL DEVICES MERGERS/ACQ Today's News On The Net - Business Wire's full file on the Internet with Hyperlinks to your home page. URL: businesswire.com Sep-11-2000 22:44 GMT Symbols: US;THAT Source BW Business Wire Regards, Elwyn